03.05.2017 22:47:00

Flotek Industries, Inc. Announces First Quarter 2017 Results And Conference Call Information

HOUSTON, May 3, 2017 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the three-months ended March 31, 2017. 

Q1 2017 Highlights:

  • First quarter revenue from continuing operations was $80.0 million, up 13.2% sequentially, and up 25.3% year-over-year.
  • GAAP loss from continuing operations for the three months ended March 31, 2017, was ($0.7 million), compared with a loss from continuing operations of less than ($0.1 million) in the same period of 2016.
  • Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, was $2.6 million for the three months ended March 31, 2017, compared to $2.6 million for the three months ended March 31, 2016. For comparable purposes to estimates, non-recurring charges of $1.1 million related to executive retirement may be considered, resulting in $3.7 million of adjusted EBITDA. We identified that we recorded $3.0 million associated with non-cash compensation which we intend to identify as non-cash adjustments to EBITDA going forward.
  • Domestic Complex nano-Fluid® (CnF®) volumes rose 24.7% and revenues were up 19.8% sequentially from the 4th quarter 2016. These volumes compare favorably to the U.S. Energy Information Administration Drilling Productivity Report which indicates U.S. land completions rose 22.8% from 4Q16 to 1Q17.
  • International CnF volumes rose 12.1% and revenues were up 4.2% sequentially from the 4th quarter 2016, comparing favorably to broader declines in sequential spending levels.
  • Expected capital expenditures for 2017 are reduced from a previous range of $15 million - $20 million as disclosed in our form 10K to a range of $10 million - $14 million, depending on market conditions, of which, approximately 40% are attributed to growth oriented projects.

Material Subsequent Events Following Q1 Close:

  • On May 2, 2017, Flotek announced the divestiture of its Drilling Technologies segment for proceeds of $17 million, subject to normal working capital adjustments.  
  • Ongoing strategic alternatives remain as substantial progress is being made towards the divestiture of our Production Technologies segment, which remains held for sale.
  • On April 25, 2017, Flotek announced a global agreement with IBM to jointly develop greater capabilities to predict and apply custom chemistry and other approaches to enhance the performance of wells throughout their entire life-cycle, highlighting our commitment to lead the effort of Big Data in the Oilfield and jointly create value for our customers.

Segment Results from Continuing Operations:

  • Flotek reported positive results from Energy Chemistry Technologies (ECT), which includes our patented suite of CnF products, but faced challenges with competitive prices in the commodity chemicals offerings.
  • Sequentially, ECT quarterly revenues increased 10.2% to $60.8 million, and year-over-year revenues for the first quarter increased 36.0% due to increased well completion activity by customers and demand for our products.
  • ECT margins in the first quarter rose by 50 basis points from the fourth quarter to 36.7%, and we expect these margins to expand through the course of the year, as price increases implemented in March, combined with process improvements, become more reflected in our results.
  • After a resilient 4th quarter which reflected 23.0% revenue growth from the 3rd quarter, the non-CnF, ECT sales revenue declined 6.1% from the 4th quarter due to timing of customer orders and key customer equipment mobilizations.
  • Consumer & Industrial Chemistry Technologies (CICT) reported revenue of $19.2 million, up 24.1% sequentially, and up 0.3% year-over-year.
  • CICT's positive growth is, in large part, attributed to flavor and fragrance sales and highlights our focus on managing the supply chain.

John Chisholm, Flotek's Chairman, President and Chief Executive Officer commented, "As anticipated, overall industry completion activity continued to improve during the quarter, and Flotek is executing on strategic initiatives and organic growth opportunities. We continue to experience increasing demand, above the industry recovery, for our patented CnF® technology. 

"Just over a year ago, the price of oil was near its recent low point and we embarked on Company-wide initiatives to position Flotek as a high-return, asset light, technology-focused Company.  We maintained our investments in research while the industry cut back, began a strategic review of our operating segments, and developed big data relationships like the recently announced IBM Watson agreement for the benefit of our shareholders and customers.

"We are excited to emerge from the industry downturn in a stronger position in our core operations, technology and relationships with an improved balance sheet and an expanding platform of growth opportunities."

First Quarter 2017 Results
For the three months ended March 31, 2017, Flotek posted revenue of $80.0 million, an increase of $16.1 million, or 25.3%, compared to $63.8 million in the same period of 2016. Revenue increased $9.3 million, or 13.2%, compared to the fourth quarter of 2016.

Flotek reported Loss from Operations for the three months ended March 31, 2017 of $0.6 million, an increase of $1.0 million compared to Income from Operations of $0.4 million in the same period of 2016. Loss from Operations decreased $5.0 million compared to fourth quarter 2016.

On a GAAP basis, Flotek reported loss per share (fully diluted) for the three months ended March 31, 2017 of ($0.01) from continuing operations compared to earnings per share (fully diluted) of $0.00 for the three months ended March 31, 2016.

Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, for the three months ended March 31, 2017, was $2.6 million, compared to $2.6 million for the three months ended March 31, 2016.

Consolidated gross margin for the three months ended March 31, 2017, was 34.7% compared to 37.3% in the same period of 2016 and relatively flat with the fourth quarter 2016 margin of 34.5%.

A summary income statement reflecting first quarter results can be found at the conclusion of this release.

First Quarter 2017 – Segment Highlights


1Q 2017

4Q 2016

% Change

1Q 2016

% Change


Energy Chemistry Technology

Revenue

$60.8 million

$55.1 million

10.2%

$44.7 million

36.0%

Gross Margin

36.7%

36.2%


42.0%


Operating Income

$8.5 million

$7.2 million

18.4%

$8.0 million

6.7%


Consumer and Industrial Chemistry Technologies ("CICT")

Revenue

$19.2 million

$15.5 million

24.1%

$19.1 million

0.3%

Gross Margin

28.3%

18.3%


26.3%


Operating Income

$3.7 million

$1.2 million

220.5%

$3.4 million

9.3%

* Percentage change may be different when calculated due to rounding.

 

Flotek Outlook
In commenting about Flotek's outlook, Mr. Chisholm added, "For the second quarter 2017, we are anticipating steady completion activity with opportunities for growth, continued demand in energy chemistry with expanding margins as the result of strategic price increases, and steady growth in our consumer and industrial chemistry technology sectors."

Conference Call Details
Flotek will host a conference call on Thursday, May 4, at 7:30 AM CDT (8:30 AM EDT) to discuss its operating results for the three months ended March 31, 2017. To participate in the call, participants should dial 800-672-8961 approximately 5 minutes prior to the start of the call. The call can also be accessed from Flotek's website at www.flotekind.com.

About Flotek Industries, Inc.
Flotek develops and delivers prescriptive chemistry-based technology, including specialty chemicals, to clients in the energy, consumer industrials and food & beverage industries. Flotek's inspired chemists draw from the power of bio-derived solvents to deliver solutions that enhance energy production, cleaning products, foods & beverages and fragrances. In the oil and gas sector, Flotek serves major and independent energy producers and oilfield service companies, both domestic and international. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit Flotek's web site at www.flotekind.com.

Forward-Looking Statements
Certain statements set forth in this Press Release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this Press Release.

Although forward-looking statements in this Press Release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, demand for oil and natural gas drilling services in the areas and markets in which the Company operates, competition, obsolescence of products and services, the Company's ability to obtain financing to support its operations, environmental and other casualty risks, and the impact of government regulation.

Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filings on Form 10-K (including without limitation in the "Risk Factors" Section), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Press Release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Press Release.

Flotek Industries, Inc.

Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings

(in thousands, except per share data)




Three Months Ended




3/31/2017


3/31/2016





GAAP Net Loss and Reconciliation to EBITDA (Non-GAAP)











Net Loss (GAAP)

$       (743)


$         (29)









Interest Expense

594


408









Income Tax Benefit

(320)


(17)









Depreciation and Amortization

3,032


2,250








EBITDA (Non-GAAP)

$      2,563


$      2,612














Select Non-Cash Items Impacting Earnings











Stock Compensation Expense

$      3,011


$      2,058









Less income tax effect at 35%

(1,054)


(720)









Stock Compensation Expense, net of tax

$      1,957


$      1,338








Weighted Average Shares Outstanding (Fully Diluted)

57,673


54,744








Stock Compensation Expense Per Share (Fully Diluted)

$        0.03


$        0.02


 

Flotek Industries, Inc.

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share data)






March 31, 2017


December 31, 2016

ASSETS


Current assets:




Cash and cash equivalents

$               1,826


$                     4,823

Accounts receivable, net of allowance for doubtful accounts of $779 and $664 at March 31, 2017 and December 31, 2016, respectively

62,934


47,152

Inventories

64,677


58,283

Income taxes receivable

12,271


12,752

Assets held for sale

27,891


43,900

Other current assets

6,694


21,708

Total current assets

176,293


188,618

Property and equipment, net

74,327


74,691

Goodwill

56,660


56,660

Deferred tax assets, net

20,044


12,894

Other intangible assets, net

49,726


50,352

TOTAL ASSETS

$          377,050


$                383,215

LIABILITIES AND EQUITY




Current liabilities:




Accounts payable

$            35,635


$                   29,960

Accrued liabilities

7,841


12,170

Interest payable

49


24

Liabilities held for sale

4,638


4,961

Current portion of long-term debt

42,603


40,566

Total current liabilities

90,766


87,681

Long-term debt, less current portion

7,083


7,833

Total liabilities

97,849


95,514

Commitments and contingencies




Equity:




Cumulative convertible preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding


Common stock, $0.0001 par value, 80,000,000 shares authorized; 59,770,452 shares issued and 57,035,414 shares outstanding at March 31, 2017; 59,684,669 shares issued and 56,972,580 shares outstanding at December 31, 2016

6


6

Additional paid-in capital

321,980


318,392

Accumulated other comprehensive income (loss)

(964)


(956)

Retained earnings (accumulated deficit)

(21,808)


(9,830)

Treasury stock, at cost; 2,046,168 and 2,028,847 shares at March 31, 2017 and December 31, 2016, respectively

(20,371)


(20,269)

Flotek Industries, Inc. stockholders' equity

278,843


287,343

Noncontrolling interests

358


358

Total equity

279,201


287,701

TOTAL LIABILITIES AND EQUITY

$          377,050


$                383,215

 

Flotek Industries, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share data)






Three Months Ended


3/31/2017


3/31/2016

Revenue

$   79,954


$   63,812

Cost of revenue

52,212


40,018

Gross profit

27,742


23,794

Expenses:




Selling, general and administrative

22,581


19,577

Depreciation and amortization

2,445


1,902

Research and development

3,141


1,947

Loss on disposal of long-lived assets

198


-

Total expenses

28,365


23,426

(Loss) income from operations

(623)


368

Other  (expense) income:




Interest expense

(594)


(408)

Other (expense) income, net

154


(6)

Total other expense

(440)


(414)

Loss before income taxes

(1,063)


(46)

Income tax benefit

320


17

Loss from continuing operations

(743)


(29)

Loss from discontinued operations, net of tax

(11,235)


(30,156)

Net loss

$ (11,978)


$ (30,185)





Basic earnings (loss) per common share:




Continuing operations

$      (0.01)


$             -

Discontinued operations, net of tax

(0.19)


(0.55)

Basic earnings (loss) per common share

$      (0.20)


$      (0.55)

Diluted earnings (loss) per common share:




Continuing operations

$      (0.01)


$             -

Discontinued operations, net of tax

(0.19)


(0.55)

Diluted earnings (loss) per common share

$      (0.20)


$      (0.55)

Weighted average common shares:




Weighted average common shares used in computing basic earnings (loss) per common share

57,673


54,744

Weighted average common shares used in computing diluted earnings (loss) per common share

57,673


54,744

 

Flotek Industries, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)



Three Months Ended


3/31/2017


3/31/2016

Cash flows from operating activities:




Net loss

$ (11,978)


$ (30,185)

Loss from discontinued operations, net of tax

(11,235)


(30,156)

Loss from continuing operations

(743)


(29)

Adjustments to reconcile loss from continuing operations to net cash used in operating activities:




Depreciation and amortization

3,032


2,250

Amortization of deferred financing costs

130


87

Loss on sale of assets

198


0

Stock compensation expense

3011


2058

Deferred income tax benefit

(7,403)


(6,898)

Reduction in tax benefit related to share-based awards

66


365

Changes in current assets and liabilities:




Accounts receivable

(15,788)


252

Inventories

(6,373)


(10,479)

Income taxes receivable

332


(10,308)

Other current assets

13,923


31

Accounts payable

5,671


5,801

Accrued liabilities

1,265


12,274

Income taxes payable

97


(1,817)

Interest payable

25


30

Net cash used in operating activities

(2,557)


(6,383)

Cash flows from investing activities:




Capital expenditures

(1,877)


(3,790)

Proceeds from sale of assets

158


-

Purchase of patents and other intangible assets

(84)


(131)

Net cash used in investing activities

(1,803)


(3,921)

Cash flows from financing activities:




Repayments of indebtedness

(750)


(1,785)

Borrowings on revolving credit facility

98,863


96,000

Repayments on revolving credit facility

(96,826)


(83,526)

Debt issuance costs

(106)


-

Reduction in tax benefit related to share-based awards

-


(365)

Purchase of treasury stock related to share-based awards

(102)


(154)

Proceeds from sale of common stock

251


212

Proceeds from exercise of stock options

7


134

Net cash provided by financing activities

1,337


10,516

Discontinued operations:




Net cash used in operating activities

(353)


(169)

Net cash provided by investing activities

353


169

Net cash flows used in discontinued operations

-


-

Effect of changes in exchange rates on cash and cash equivalents

26


60

Net (decrease) increase in cash and cash equivalents

(2,997)


272

Cash and cash equivalents at the beginning of period

4,823


2,208

Cash and cash equivalents at the end of period

$      1,826


$      2,480

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/flotek-industries-inc-announces-first-quarter-2017-results-and-conference-call-information-300451049.html

SOURCE Flotek Industries, Inc.

Nachrichten zu Flotek Industries IncShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Flotek Industries IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!